This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations by Jennifer Iwamoto
Introduction
Jennifer Iwamoto is an accomplished inventor based in Seattle, WA. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on lipid nanoparticles. Her research focuses on enhancing the efficacy of drug formulations, which can lead to improved treatment outcomes.
Latest Patents
Jennifer Iwamoto holds a patent for a "Multiple drug lipid nanoparticle composition and related methods for extended drug levels in blood and lymph tissue." This patent describes multi-drug lipid nanoparticles that stably incorporate multiple small molecule drugs with varying hydrophobic and water solubility characteristics. The disclosed compositions and methods provide enhanced stability of lipid nanoparticle drug formulations, allowing for a prolonged presence of drugs in the body. This innovation addresses different mechanistic targets and helps avoid single drug resistance, making it a significant advancement in the field.
Career Highlights
Jennifer is affiliated with the University of Washington, where she continues her research and development in drug delivery systems. Her work has garnered attention for its potential to revolutionize treatment protocols for various medical conditions.
Collaborations
Jennifer collaborates with Rodney J Y Ho, who is also involved in research related to drug delivery systems. Their combined expertise contributes to the advancement of innovative solutions in the pharmaceutical field.
Conclusion
Jennifer Iwamoto's contributions to the field of drug delivery through her innovative patent demonstrate her commitment to improving medical treatments. Her work at the University of Washington continues to pave the way for advancements in pharmaceutical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
